| Endogenous control mechanisms of FAK and PYK2 and their relevance to cancer development R Naser, A Aldehaiman, E Díaz-Galicia, ST Arold Cancers 10 (6), 196, 2018 | 66 | 2018 |
| Cancer-associated mutations in the p85α N-terminal SH2 domain activate a spectrum of receptor tyrosine kinases X Li, AYT Lau, ASN Ng, A Aldehaiman, Y Zhou, PKS Ng, ST Arold, ... Proceedings of the National Academy of Sciences 118 (37), e2101751118, 2021 | 19 | 2021 |
| The exceptionally efficient quorum quenching enzyme LrsL suppresses Pseudomonas aeruginosa biofilm production ZU Rehman, AA Momin, A Aldehaiman, T Irum, R Grünberg, ST Arold Frontiers in Microbiology 13, 977673, 2022 | 16 | 2022 |
| Methods for the recombinant expression of active tyrosine kinase domains: Guidelines and pitfalls MED Galicia, A Aldehaiman, SB Hong, ST Arold, R Grünberg Methods in Enzymology 621, 131-152, 2019 | 11 | 2019 |
| Synergy and allostery in ligand binding by HIV-1 Nef A Aldehaiman, AA Momin, A Restouin, L Wang, X Shi, S Aljedani, S Opi, ... Biochemical Journal 478 (8), 1525-1545, 2021 | 7 | 2021 |
| Functional selection in SH3-mediated activation of the PI3 kinase SS Aljedani, A Aldehaiman, A Sandholu, S Alharbi, VCY Mak, H Wu, ... bioRxiv, 2024 | | 2024 |
| The implications of allosteric sites on SH3-mediated signaling A Aldehaiman | | 2022 |
| Scaled, unmerged X-ray diffraction data from SF2 Nef-Fyn SH3 R96I crystals ST Arold, A Aldehaiman, UF Shahul Hameed KAUST Research Repository, 2020 | | 2020 |
| Endogenous Control Mechanisms of FAK and PYK2 and Their Relevance to Cancer Development and Therapy R Naser, A Aldehaiman, MED Galicia, ST Arold Preprints, 2018 | | 2018 |
